Abstract
The modulatory effects of noradrenergic agonists on the 25 mM K+-induced release of [3H]dopamine (3H-DA) from rat brain nucleus accumbens slices was investigated, using a superfusion technique. The K+-induced release of3H-DA was Ca2+ dependent, significantly enhanced (25–32%;p<0.02) by the β-adrenoceptor agonist isoproterenol (10 μM), and significantly decreased (13–25%;p<0.05) by the α2-adrenoceptor agonist clonidine (10 μM). At these concentrations neither drug affected basal release of3H-DA. Clonidine (100 μM) increased the basal release of3H-DA, while decreasing the K+-induced release by 19% (p<0.01). The inclusion of desipramine in the incubation medium, to prevent accumulation of3H-DA into noradrenergic neurons, did not alter the inhibitory effect of clonidine (10 μM) on3H-DA release. This study provides direct evidence that noradrenergic neurons can modulate dopaminergic neurotransmission in the mesolimbic system.
Similar content being viewed by others
References
Kostowski, W. 1981. Brain noradrenaline, depression and antidepressant drugs: Facts and hypothesis. TIPS 2:314–317.
Jenner, P., Sheehy, M., andMarsden, C. D. 1983. Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: Implications for the treatment of Parkinson's disease. Br. J. Clin. Pharmacol. 15:277S-289S.
Fibiger, H. C., andPhillips, A. G. 1981. Increased intracranial self-stimulation in rats after long-term administration of desipramine. Science 214:683–685.
Garrigues, A., andCazala, P. 1983. Central catecholamine metabolism and hypothalamic self-stimulation behaviour in two inbred strains of mice. Brain Res. 265:265–271.
Antelman, S. M., andCaggiula, A. R. 1977. Norepinephrine-dopamine interactions and behaviour. Science 195:646–653.
Kostowski, W. 1980. Noradrenergic interactions among central neurotransmitters. Pages 47–65,in Essman, W. B. (ed.), Neurotransmitters, Receptors and Drug Action, Spectrum Publ. Inc., New York.
Starke, K. 1981. Presynaptic receptors. Ann. Rev. Pharmacol. Toxicol. 21:7–30.
De Belleroche, J. S., andBradford, H. F. 1980. Presynaptic control of the synthesis and release of dopamine from striatal synaptosomes: A comparison between the effects of 5-hydroxytryptamine, acetylcholine, and glutamate. J. Neurochem. 35:1227–1234.
Ennis, C., Kemp, J. D., andCox, B. 1981. Characterisation of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. J. Neurochem. 36:1515–1520.
Westfall, T. C., andTittermary, V. 1982. Inhibition of the electrically induced release of [3H]dopamine by serotonin from superfused rat striatal slices. Neurosci. Lett. 28:205–209.
De Belleroche, J., andGardiner, I. M. 1982. Contrasting effects of 5-hydroxytryptamine on the release of dopamine and acetylcholine in the nucleus accumbens of rat. J. Neural. Trans. 55:227–242.
McCarthy, B. W., Reyneke, L., Rousseau, J., Taljaard, J. J. F., andNeethling, A. C. 1982. Neurotransmitter release studies: A versatile approach to data handling. S. Afr. J. Sci. 78:333–334.
De Langen, C. D. J., Hogenboom, F., andMulder, A. H. 1979. Presynaptic noradrenergic α-receptors and modulation of3H-noradrenaline release from rat brain synaptosomes. Eur. J. Pharmacol. 60:79–89.
Rubin, R. P. 1970. The role of calcium in the release of neurotransmitter substances and hormones. Pharmacol. Rev. 22:389–428.
Cerrito, F., Casazza, G., Levi, G., andRaiteri, M. 1980. Evidence for a similar compartmentation of recaptured and endogenously synthesized dopamine in striatal synaptosomes. Neurochem. Res. 5:115–121.
Mulder, A. H. Van Den Berg, W. B., andStoof, J. C. 1975. Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system. Brain Res. 99:419–424.
Hoffmann, I. S., Naylor, R. J., andCubeddu, L. X. 1980. Presynaptic effects of 2-aminotetralins on striatal dopaminergic neurons. J. Pharmacol. Exp. Therap. 215:486–493.
Fischer, J. F., andCho, A. K. 1979. Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model. J. Pharmacol. Exp. Therap. 208:203–209.
George, S. R. andVan Loon, G. R. 1982. Characterization of high affinity dopamine uptake into the dopamine neurons of the hypothalamus. Brain Res 234:339–355.
Ueda, H., Goshima, Y., andMisu, Y. 1983. Presynaptic mediation by α1-,β1,β2-adrenoceptors of endogenous noradrenaline and dopamine release from slices of rat hypothalamus. Life Sci. 33:371–376.
Liang, N. Y., andRutledge, C. O. 1982. Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem. Pharmacol. 31:2479–2484.
Lindvall, O., andBjörklund, A. 1974. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol. Scand. 412 (suppl.):1–48.
O'Donohue, T. L., Crowley, W. R., andJacobwitz, D. M. 1979. Biochemical mapping of the noradrenergic ventral bundle projection sites: Evidence for a noradrenergic-dopaminergic interaction. Brain Res. 172:87–100.
Kelly, P. H., Seviour, P. W., andIversen, S. D. 1975 Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res. 94:507–522.
Spyraki, C., andFibiger, H. C. 1981. Behavioural evidence for supersensitivity of postsynaptic dopamine receptors in the mesolimbic system after chronic administration of desipramine. Eur. J. Pharmacol. 74:195–206.
Maj, J., Rogóz, Z., Skuza, G., andSowínska, H. 1983. Reserpine-induced locomotor stimulation in mice chronically treated with typical and atypical antidepressants. Eur. J. Pharmacol. 87:469–474.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nurse, B., Russell, V.A. & Taljaard, J.J.F. α2 and β-adrenoceptor agonists modulate [3H]dopamine release from rat nucleus accumbens slices: Implications for research into depression. Neurochem Res 9, 1231–1238 (1984). https://doi.org/10.1007/BF00973036
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00973036